Skip to main content
SANTEN PHARMACEUTICAL CO.,LTD. logo

SANTEN PHARMACEUTICAL CO.,LTD. — Investor Relations & Filings

Ticker · 4536 ISIN · JP3336000009 LEI · 529900TPT3I7C17MIM03 T Manufacturing
Open in API
Filings indexed 78 across all filing types
Latest filing 2025-12-15 Transaction in Own Shar…
Country JP Japan
Listing T 4536

About SANTEN PHARMACEUTICAL CO.,LTD.

https://www.santen.com/en

Santen Pharmaceutical Co., Ltd. is a global company specializing in ophthalmology. It is engaged in the research, development, manufacturing, sales, and marketing of pharmaceutical products and medical devices dedicated to eye health. The company's portfolio includes prescription and over-the-counter pharmaceuticals that address a wide range of ophthalmic conditions. Serving patients, consumers, and medical professionals in over 60 countries, Santen aims to contribute to the realization of “Happiness with Vision” by providing valuable products and services worldwide.

Recent filings

Filing Released Lang Actions
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 1% confidence The document is a 'Report on Status of Purchase of Own Shares' (自己株券買付状況報告書) filed under Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act of Japan. It details the company's share buyback activities, including the number of shares acquired, the total cost, and the status of treasury shares. This falls directly under the definition of 'Transaction in Own Shares' (POS).
2025-12-15 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 1% confidence The document is a '自己株券買付状況報告書' (Report on Status of Purchase of Own Shares) filed under Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act of Japan. It details the company's share buyback activity for the period of October 2025, including specific dates, number of shares purchased, and total costs. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-11-14 Japanese
確認書
Regulatory Filings Classification · 1% confidence The document is a 'Confirmation Letter' (確認書) filed under Article 24-5-2 of the Financial Instruments and Exchange Act of Japan. It serves as an officer certification regarding the accuracy of the contents of a semi-annual report. According to the 'Certification Rule', documents that are primarily officer certifications or attestations, even if they reference a specific report type, should be classified as Regulatory Filings (RNS) rather than the report itself. The document does not contain the actual financial statements or substantive financial data required for an Interim Report (IR). H1 2025
2025-11-10 Japanese
半期報告書－第114期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 1% confidence The document is a '半期報告書' (Semi-Annual Report) filed by Santen Pharmaceutical Co., Ltd. with the Kanto Local Finance Bureau. It contains detailed financial statements, management analysis (MDA), and business performance metrics for the interim period (April 1, 2025, to September 30, 2025). This document is a formal regulatory filing required under the Financial Instruments and Exchange Act of Japan, which corresponds to the 'Interim / Quarterly Report' category in the provided schema. H1 2026
2025-11-10 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 1% confidence The document is a 'Report on the Status of Acquisition of Treasury Shares' (自己株券買付状況報告書) filed under Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act of Japan. This is a formal regulatory filing detailing the company's share buyback activities for a specific period (September 2025). Since the document specifically reports the execution of share repurchases (buybacks) rather than just an announcement of intent or a general regulatory notice, it falls under the 'Transaction in Own Shares' category.
2025-10-15 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 1% confidence The document is a '自己株券買付状況報告書' (Report on Status of Acquisition of Treasury Shares) filed under Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act of Japan. This document details the company's share buyback activity for the month of August 2025, including daily transaction volumes and total costs. According to the provided filing definitions, reports regarding a company buying back its own shares are classified as 'Transaction in Own Shares' (POS).
2025-09-12 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.